ASM-024

DRUG4 trials

Sponsors

Asmacure Ltée

Conditions

AsthmaCOPDMild Allergic Asthma

Phase 1

Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

TerminatedNCT01793298

Asmacure LtéeAsthma

Start: 2013-03-31End: 2014-12-31Updated: 2015-02-10

Phase 2

Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma

CompletedNCT01092403

Asmacure LtéeMild Allergic Asthma

Start: 2010-04-30End: 2012-01-31Updated: 2012-01-26

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

CompletedNCT01190826

Asmacure LtéeAsthma

Start: 2010-08-31End: 2012-02-29Updated: 2012-03-15

Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT01855230

Asmacure LtéeCOPD

Start: 2013-08-31End: 2014-12-31Updated: 2014-12-16